Prosecution Insights
Last updated: October 02, 2026

Corvia Medical Inc.

Technology area: Medical Devices & Mechanical Engineering

2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Corvia Medical Inc. is active in the Medical Devices & Mechanical Engineering technology area, where it currently has 2 pending office actions. These matters are being reviewed by 2 distinct examiners. This indicates that the company is dealing with different individuals at the patent office for each of its active cases, requiring a strategy that accounts for varied examiner behaviors.

The busiest examiner for the portfolio is PRESTON, REBECCA STRASZHEIM, who holds 1 busiest examiner pending action. All current prosecution is concentrated within 1 distinct art unit. This structure suggests that while the technical focus remains narrow, the company must navigate the specific preferences and styles of multiple reviewers simultaneously. Such a distribution within a single administrative group can lead to inconsistent results if the examiners interpret the same art unit guidelines differently.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (50%)
1
Medium (50%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (50%)
Multi-statute (no §101)1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
50% of docket
1
Business / Other
50% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PRESTON, REBECCA STRASZHEIM 1 73.9% +38.6%
YANG, CHENG FONG 1 62.8% +22.5%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18741564 DEVICES AND METHODS FOR CORONARY SINUS PRESSURE RELIEF PRESTON, REBECCA STRASZHEIM —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18741564 DEVICES AND METHODS FOR CORONARY SINUS PRESSURE RELIEF PRESTON, REBECCA STRASZHEIM —
18416440 DEVICES AND METHODS FOR TREATING HEART FAILURE YANG, CHENG FONG —

Top Art Units

Art UnitApps
3781 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18741564 DEVICES AND METHODS FOR CORONARY SINUS PRESSURE RELIEF PRESTON, REBECCA STRASZHEIM — §103§112 Non-Final OA — Pending Jun 12, 2024
18416440 DEVICES AND METHODS FOR TREATING HEART FAILURE YANG, CHENG FONG 3781 §103 Final Rejection — Pending Jan 18, 2024

Managing Corvia Medical Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month